Scleroderma Foundation eLetter

Archive

Scleroderma: Summaries of Research

NIAMS created this document because it frequently receives requests from the public about the status of the studies listed in the 2002 press release, "Scleroderma Research Receives a Boost From Multiple NIH Grants."

Topics include:

Study Examines Early Immune System Targets in Scleroderma

Mouse Model Helps Researchers Understand Fibrosis

Study Downplays Persistent Infection as Cause of Scleroderma

Scientists Discover Role of Antibodies to RNA in Scleroderma

Scientists Learn How Chemicals May Cause Scleroderma

Study Looks at Cell Changes That Lead to Scleroderma

Studies Look at Different ‘Cards’ in the Scleroderma ‘Hand’

Mouse Models Offer Clues to Process of Skin Thickening


Friday, March 2, 2007– Issue #183	eLetter Archive

It's A ... New Home Page

The Scleroderma Foundation today unveiled a new home page on its Web site. The new page at www.scleroderma.org was created to provide easier content access for all visitors.

Atop the Leaderboard

So far, so great. The first four events of the 100 by $1,000 project have far exceeded expectations. To date, $18,000 has been raised through a combination of golf tournaments and donations. That dollar figure is well beyond the $1,000 per event that organizers had anticipated.

Accentia Biopharmaceuticals Acquires Worldwide Exclusive License to Revimmune for All Autoimmune Diseases

Revimmune uses an approved drug in a new patent-pending method to eliminate autoimmunity: In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90% of cases refractory to standard therapies.

Systemic Sclerosis: a Prototypic Multisystem Fibrotic Disorder

by John Varga, M.D. and Dr. David Abraham

A unique feature of systemic sclerosis (SSc) that distinguishes it from other fibrotic disorders is that autoimmunity and vasculopathy characteristically precede fibrosis.

Watch David Gilliland Race!

Racing partner David Gilliland will participate in the Telcel-Motorola 200 this Sunday at 1:30 p.m. The race will be held in Mexico City, and Gilliland will be behind the wheel of a new #25 Ford Fusion. The event will be broadcast live on ESPN 2 and NASCAR.com. Last week, Gilliland was ill and unable to participate in the Busch Series race.

Upcoming Events

	March 8 (Thurs.): Michigan Chapter Patient Education Days (Farmington, Mich.)
	March 10 (Sat.): 100 by $1,000 Golf Clinic (Vero Beach, Fla.)
	March 17 (Sat.): Missouri Chapter's Educational Forum (St. Louis, Mo..)
	March 24 (Sat.): Scleroderma Oregon Chapter Presents 6th Annual Cheri Woo Education Seminars (Portland, Ore.)
	March 31 (Sat.): Connecticut Scleroderma Support and UConn Health Center Support Ed Forum (Farmington, Conn.)
	March 31– April 1 (Sat. & Sun.): St. Paul Women's Expo (St. Paul, Minn.)
	July 20–22 (Fri.–Sun.): Scleroderma Foundation's National Conference (Philadelphia, Penn.)
SF Calendar

Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923
Phone 978-463-5843 · 800-722-HOPE (4673)

If you cannot view the eLetter, or the links do not work, you can read it on the Web at www.scleroderma.org/e-letters/eLetter_183.htm. If someone has forwarded this eLetter to you, and you wish to subscribe to this FREE weekly publication, go to www.scleroderma.org/e_letter_signup.shtm.